Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Journal of Clinical Pharmacology|September 3, 2004
Intramuscular haloperidol or lorazepam and QT intervals in schizophreniaAnne T Harvey, David Flockhart, J Christopher Gorski, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 18, 2006
Differential effects of NMDA and AMPA glutamate receptors on functional magnetic resonance imaging signals and evoked neuronal activity during forepaw stimulation of the ratWilly Gsell, Michael Burke, Dirk Wiedermann, et al.
Violence and Victims|November 2, 2021
Nurturing Hope and Well-Being Among Survivors of Domestic Violence Within the Family Justice Center ModelChan M Hellman, Casey Gwinn, Gael Strack, et al.
Autoimmunity|July 26, 2005
Autoantibodies profile of rheumatoid arthritis patients during treatment with infliximabOri Elkayam, Michael Burke, Nurit Vardinon, et al.
Atherosclerosis|September 24, 2004
Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive proteinDavid Zeltser, Ori Rogowski, Tamar Mardi, et al.
BJGP Open|November 28, 2019
Experiences of primary healthcare professionals and patients from an area of urban disadvantage: a qualitative studyJennifer Reath, Marlee King, Walter Kmet, et al.
ACS Applied Materials & Interfaces|March 29, 2021
Gold-Decorated Silicon Nanowire Photocatalysts for Intracellular Production of Hydrogen PeroxideAndrew W Phillips, Ramya Parameswaran, Emma Lichter, et al.
Physiological Measurement|May 21, 2024
A cross species thermoelectric and spatiotemporal analysis of alternans in live explanted hearts using dual voltage-calcium fluorescence optical mappingAnna Crispino, Alessandro Loppini, Ilija Uzelac, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|June 19, 2004
Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy onesOri Rogowski, David Zeltser, Itzhak Shapira, et al.
Drug Delivery|May 22, 2018
Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical modelPhilip J Kuehl, Marcie J Grimes, Devon Dubose, et al.
Pageof 12